Today’s top gainers include the company AbbVie Inc. (NYSE:ABBV) which is in the industry Drug Manufacturers – Major, gaining 0.14% today. In the last week its performance is -0.76%, and 2.97% for the past quarter. Currently, AbbVie Inc., ABBV has a target price of 71.37, so today’s gain of 0.14% is a significant step towards its target price. The GAP today is therefore 0.53%.
AbbVie Inc. (NYSE:ABBV), has a market cap of 104275.8, and is based in USA. Insider ownership is at 0.10%, and institutional ownership is 71.90%.
At the current price of 64.12, it has a dividend yield of 3.56%, and its target price is 71.37. This is with a profit margin of 23.10%, and total debt/equity of 6.71. AbbVie Inc. (NYSE:ABBV) has a P/E of 18.38, as well as a forward P/E of 11.25.
With a current EPS of 3.49, and a forecasted EPS growth for next year at 18.60%,AbbVie Inc. (NYSE:ABBV) has had a EPS growth for the past five years at 3.50%. For the next five years EPS growth is projected to be 16.25%.
Performance for the year is 8.15%. Since its IPO date on 1/2/2013, the total performance to date is 11.39%.
Volume today for AbbVie Inc. (NYSE:ABBV), is 4071800, while its average volume is 7810.08. Whilst the total gain today was 0.14%, it did have a day high of -5.87%.
Volatility for this week has been at 1.12%, and 1.34% for the month. The 52-week low for AbbVie Inc., ABBV has been 45.19%, while the 52-week-high has reached -5.87%.
Looking at its return of investments, which is 16.90%, and its return on assets is 10.00%. AbbVie Inc. (NYSE:ABBV) has an operating margin of 35.00%. With a sales growth of 17.80% quarter over quarter. Bearing in mind that AbbVie Inc., ABBV is in the sector Healthcare, its long-term debt/equity is 6.62, and has a current ratio of 1.8 and 1.6 for quick ratio.
So what is the value of AbbVie Inc.? Well its PEG is 1.13, and the P/S is 4.21, along with a P/B of 18.48. Meanwhile it has a p/cash of 13.03.